icon-folder.gif   Conference Reports for NATAP  
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
Rising and Higher Healthcare Resource Utilization (HCRU) and Costs of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Liver Disease of Increasing Severity - Results of a US Real-World Analysis
  Reported by Jules Levin -
AASLD: The Liver Meeting, November 9-13, 2018, San Francisco, CA AASLD2018
AASLD Wong, Kachru N2, Meyer N3, Gordon S4
1Division of Gastroenterology and Hepatology, Alameda Health System, Highland Hospital, Oakland, CA;
2Gilead Sciences, Health Economics Outcomes Research (HEOR), Foster City, CA; 3IBM Watson Health, Cambridge, MA; 4Henry Ford Hospital, Wayne State University School of Medicine, Detroit, MI








1. Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10, 330-344 (2013).
2. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008;49:608-612.